Oppenheimer Asset Management’s BioLife Solutions BLFS Stock Holding History

Oppenheimer Asset Management’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-18,138	Closed	-$391K	–	1165
2025 Q2	$391K	Buy	18,138 +1,203	+7%	+$27.1K	﹤0.01%	925
2025 Q1	$387K	Buy	16,935 +172	+1%	+$4.53K	﹤0.01%	912
2024 Q4	$435K	Sell	16,763 -9,146	-35%	-$228K	0.01%	897
2024 Q3	$649K	Sell	25,909 -7,387	-22%	-$174K	0.01%	822
2024 Q2	$714K	Buy	33,296 +15,252	+85%	+$296K	0.01%	780
2024 Q1	$335K	Buy	+18,044	New	+$316K	﹤0.01%	934
2020 Q1	–	Sell	-1,189	Closed	-$19K	–	1517
2019 Q4	$19K	Sell	1,189 -82	-6%	-$1.33K	﹤0.01%	1457
2019 Q3	$21K	Sell	1,271 -47	-4%	-$882	﹤0.01%	1453
2019 Q2	$22K	Buy	+1,318	New	+$23K	﹤0.01%	1466

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

Oppenheimer Asset Management's BLFS Position: Q3 2025 in Review

Oppenheimer Asset Management sold out of BioLife Solutions (BLFS) in Q3 2025, closing a stake of 18,138 shares — an estimated $391K sold.

Oppenheimer Asset Management first reported a position in BLFS in Q2 2019 and held it in 9 quarters. The position peaked at $714K in Q2 2024. 192 funds tracked by Wall St. Rank hold BLFS as of Q3 2025.

Oppenheimer Asset Management reported no remaining BioLife Solutions position as of Q3 2025 after selling out during the quarter.
Oppenheimer Asset Management sold 18,138 BioLife Solutions shares in Q3 2025, an estimated $391K.
Oppenheimer Asset Management first reported a position in BioLife Solutions in Q2 2019 and held it in 9 quarters.
Oppenheimer Asset Management's BioLife Solutions position peaked at $714K in Q2 2024.
192 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2025.

Based on Oppenheimer Asset Management's 13F filing for Q3 2025, filed 6 Nov 2025.